|
|
||||||||
Genomics |
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK1
Department of Chemistry, Box 351700, University of Washington, Seattle, WA 98195-1700, USA2
Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK3
The Laboratory of Molecular Biophysics, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK4
Author for correspondence: Edith Sim. Tel: +44 1865 271596. Fax: +44 1865 271853. e-mail: esim{at}molbiol.ox.ac.uk
Arylamine N-acetyltransferases (NATs) are enzymes involved in the detoxification of a range of arylamine and hydrazine-based xenobiotics. NATs have been implicated in the endogenous metabolism of p-aminobenzoyl glutamate in eukaryotes, although very little is known about the distribution and function of NAT in the prokaryotic kingdom. Using DNA library screening techniques and the analysis of data from whole-genome sequencing projects, we have identified 18 nat-like sequences from the Proteobacteria and Firmicutes. Recently, the three-dimensional structure of NAT derived from the bacterium Salmonella typhimurium (PDB accession code 1E2T) was resolved and revealed an active site catalytic triad composed of Cys69-His107-Asp122. These residues have been shown to be conserved in all prokaryotic and eukaryotic NAT homologues together with three highly conserved regions which are found proximal to the active site triad. The characterization of prokaryotic NATs and NAT-like enzymes is reported. It is also predicted that prokaryotic NATs, based on gene cluster composition and distribution amongst genomes, participate in the metabolism of xenobiotics derived from decomposition of organic materials.
Keywords: gene cluster, NAT, prokaryotic, endogenous function
Abbreviations: NAT, arylamine N-acetyltransferase encoded by nat in prokaryotes and NAT in eukaryotes; INH, isoniazid; p-ABA, p-aminobenzoic acid; RAS, rifamycin amide synthase
This article has been cited by other articles:
![]() |
J. M. Walraven, D. F. Barker, M. A. Doll, and D. W. Hein Tissue Expression and Genomic Sequences of Rat N-acetyltransferases rNat1, rNat2, rNat3, and Functional Characterization of a Novel rNat3*2 Genetic Variant Toxicol. Sci., October 1, 2007; 99(2): 413 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Walraven, J. O. Trent, and D. W. Hein Computational and Experimental Analyses of Mammalian Arylamine N-Acetyltransferase Structure and Function Drug Metab. Dispos., June 1, 2007; 35(6): 1001 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Suzuki, Y. Ohnishi, and S. Horinouchi Arylamine N-Acetyltransferase Responsible for Acetylation of 2-Aminophenols in Streptomyces griseus J. Bacteriol., March 1, 2007; 189(5): 2155 - 2159. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sholto-Douglas-Vernon, J. Sandy, T. C Victor, E. Sim, and P. D. Helden Mutational and expression analysis of tbnat and its response to isoniazid J. Med. Microbiol., December 1, 2005; 54(12): 1189 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhakta, G. S. Besra, A. M. Upton, T. Parish, C. Sholto-Douglas-Vernon, K. J.C. Gibson, S. Knutton, S. Gordon, R. P. daSilva, M. C. Anderton, et al. Arylamine N-Acetyltransferase Is Required for Synthesis of Mycolic Acids and Complex Lipids in Mycobacterium bovis BCG and Represents a Novel Drug Target J. Exp. Med., May 3, 2004; 199(9): 1191 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mushtaq, M. Payton, and E. Sim The COOH Terminus of Arylamine N-Acetyltransferase from Salmonella typhimurium Controls Enzymic Activity J. Biol. Chem., March 29, 2002; 277(14): 12175 - 12181. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Diaz, A. Ferrandez, M. A. Prieto, and J. L. Garcia Biodegradation of Aromatic Compounds by Escherichia coli Microbiol. Mol. Biol. Rev., December 1, 2001; 65(4): 523 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Payton, C. Gifford, P. Schartau, C. Hagemeier, A. Mushtaq, S. Lucas, K. Pinter, and E. Sim Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis Microbiology, December 1, 2001; 147(12): 3295 - 3302. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |